#Pharma #Bourse Glaxo's diabetes drug fails to beat Takeda's Actos in head-to-head study - FierceBiotech http://t.co/04YbQqHccm
June 26, 2013
Publicité
/http%3A%2F%2Fassets.fiercemarkets.net%2Fpublic%2Fopengraphimages%2Fopengraph_fiercebiotech.png)
Glaxo's diabetes drug fails to beat Takeda's Actos in head-to-head study
CHICAGO--GlaxoSmithKline's ($GSK) experimental diabetes drug proved to be at least as good at controlling blood sugar as most--but not one--in a series of late-stage trials reported Monday, building on a body of mixed performances in clinical trials of the weekly therapy.